US FDA to review bladder cancer risks for pioglitazone

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

FDA.FDA reviewing preliminary safety information on Actos (pioglitazone). Internet Document: [1 page], 17 Sep 2010. Available from: URL: http://www.fda.gov

US FDA to review bladder cancer risks for pioglitazone. React. Wkly. 1320, 2 (2010). https://doi.org/10.2165/00128415-201013200-00002

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.